Originally discovered and developed by Eli Lilly , Oritavancin was taken over by InterMune in 2001 and in late 2005 by Targanta Therapeutics .
Originally acquired by Eli Lilly , oritavancin was discovered and developed by InterMune in 2001 and then by Targanta Therapeutics in late 2005 .